Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hematologic Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 3Pancreatic Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Leukemia, Myeloid, Acute 1Hepatitis B 1Glioma 1Depression 1Brenner Tumor 1Astrocytoma 1Anxiety Disorders 1

Interventions

Cytarabine 84Cyclophosphamide 58Azacitidine 57fludarabine 51venetoclax 41fludarabine phosphate 40Busulfan 30Whole-Body Irradiation 22Filgrastim 22Decitabine 21Mycophenolic Acid 20Methotrexate 19Mitoxantrone 18Etoposide 18Antilymphocyte Serum 18Cyclosporine 17Clofarabine 17Tacrolimus 16Peripheral Blood Stem Cell Transplantation 15Granulocyte Colony-Stimulating Factor 15Daunorubicin 15Melphalan 13thymoglobulin 11Thiotepa 11Stem Cell Transplantation 11Interleukin-2 11Idarubicin 9Gemtuzumab 9Cord Blood Stem Cell Transplantation 9aldesleukin 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid, Acute × Practice Guidelines as Topic × Clear all
NCT03108911 2017-11-17

Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy

Rutgers, The State University of New Jersey

Phase 2 Terminated
1 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡